Relationships between polymorphisms of the human serum paraoxonase gene and insulin sensitivity in Japanese patients with Type 2 diabetes

被引:11
作者
Ikeda, Y [1 ]
Suehiro, T [1 ]
Ohsaki, F [1 ]
Arii, K [1 ]
Kumon, Y [1 ]
Hashimoto, K [1 ]
机构
[1] Kochi Med Sch, Dept Internal Med 2, Nanko Ku, Kochi 7838505, Japan
关键词
human serum paraoxonase; PON1; genetic polymorphism; insulin sensitivity;
D O I
10.1016/S0168-8227(02)00280-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human serum paraoxonase (PON1), which is associated with HDL, is an esterase and has been shown to reduce the susceptibility of LDL to lipid peroxidation. The objective of the study was to determine whether genetic polymorphisms of the PON1 gene are associated with insulin sensitivity. Forty-eight Japanese patients with type 2 diabetes were recruited, and euglycemic hyperinsulinemic clamp was performed to assess insulin sensitivity. The PON1 promoter polymorphism C(-108)T was determined by direct sequencing, and the coding region polymorphism Q192R was determined by polymerase chain reaction and digestion of the amplified fragments. No association was observed between the Q192R polymorphism and the glucose infusion rate (GIR), whereas GIR increased with the following order of genotypes: -108TT<-108CT< and -108CC (4.2+/-1.6, 5.1+/-2.5, and 6.9+/-2.5 mg kg(-1) min(-1), respectively; P<0.02, ANCOVA). Stepwise regression analysis revealed that the C(-108)T polymorphism significantly contributed to the GIR. It has been reported that oxidative stress attenuates insulin signaling in vitro. The PON1 promoter polymorphism C(-108)T may influence insulin sensitivity by modulating serum antioxidant capacity. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 27 条
[1]   SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]  
ADKINS S, 1993, AM J HUM GENET, V52, P598
[3]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[4]   IDENTIFICATION OF A DISTINCT HUMAN HIGH-DENSITY-LIPOPROTEIN SUBSPECIES DEFINED BY A LIPOPROTEIN-ASSOCIATED PROTEIN, K-45 - IDENTITY OF K-45 WITH PARAOXONASE [J].
BLATTER, MC ;
JAMES, RW ;
MESSMER, S ;
BARJA, F ;
POMETTA, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03) :871-879
[5]  
Cao HB, 1999, J LIPID RES, V40, P133
[6]   Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers [J].
Carantoni, M ;
Abbasi, F ;
Warmerdam, F ;
Klebanov, M ;
Wang, PW ;
Chen, YDI ;
Azhar, S ;
Reaven, GM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) :762-767
[7]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, P214
[8]   An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians [J].
Hanson, RL ;
Ehm, MG ;
Pettitt, DJ ;
Prochazka, M ;
Thompson, DB ;
Timberlake, D ;
Foroud, T ;
Kobes, S ;
Baler, L ;
Burns, DK ;
Almasy, L ;
Blangero, J ;
Garvey, WT ;
Bennett, PH ;
Knowler, WC .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (04) :1130-1138
[9]   THE MOLECULAR-BASIS OF THE HUMAN SERUM PARAOXONASE ACTIVITY POLYMORPHISM [J].
HUMBERT, R ;
ADLER, DA ;
DISTECHE, CM ;
HASSETT, C ;
OMIECINSKI, CJ ;
FURLONG, CE .
NATURE GENETICS, 1993, 3 (01) :73-76
[10]   Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus [J].
Ikeda, Y ;
Suehiro, T ;
Inoue, M ;
Nakauchi, Y ;
Morita, T ;
Arii, K ;
Ito, H ;
Kumon, Y ;
Hashimoto, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (05) :598-602